Please enable JavaScript to continue using this application.

Compare $IVVD vs $RNAC | Chartloom

Compare

$IVVD vs $RNAC

Invivyd Inc · Cartesian Therapeutics Inc

IVVD

Invivyd Inc

RNAC

Cartesian Therapeutics Inc

Compare $IVVD vs $RNAC

Comparing Invivyd Inc and Cartesian Therapeutics Inc

IVVDInvivyd Inc

RNACCartesian Therapeutics Inc

IVVDInvivyd Inc

Market cap

$212M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.13x

Rev growth (TTM)

26.3%

YTD performance

-71.2%

52W performance

-56.0%

FCF yield

-51.6%

RNACCartesian Therapeutics Inc

Market cap

$207M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

473.62x

Rev growth (TTM)

-20.7%

YTD performance

4.4%

52W performance

-31.0%

FCF yield

-37.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IVVD

RNAC

Detailed metrics comparison

IVVD

Invivyd Inc

RNAC

Cartesian Therapeutics Inc

Market Cap

IVVD$212M

RNAC$207M

Enterprise Value

IVVD$52M

RNAC$113M

Price

IVVD$0.72

RNAC$7.06

P/E Ratio

IVVDN/A

RNACN/A

P/S Ratio

IVVD3.64x

RNAC140.34x

EV/Sales

IVVD0.90x

RNAC76.18x

EV/EBITDA

IVVD0.00x

RNAC0.00x

P/B Ratio

IVVD1.34x

RNAC296.12x

P/FCF Ratio

IVVDN/A

RNACN/A

EV/FCF

IVVD-0.48x

RNAC-1.43x

PEG Ratio

IVVDN/A

RNACN/A

Forward P/E (NTM)

IVVDN/A

RNACN/A

Forward P/S (NTM)

IVVD3.13x

RNAC473.62x

Revenue (TTM)

IVVD$58M

RNAC$1M

Revenue Growth (YoY)

IVVD26.3%

RNAC-20.7%

Forward Rev Growth

IVVD44.8%

RNAC-14.0%

Gross Margin (TTM)

IVVD92.2%

RNAC0.0%

Operating Margin (TTM)

IVVD0.0%

RNAC0.0%

EBITDA Margin (TTM)

IVVD-191.7%

RNAC-6503.1%

Net Margin (TTM)

IVVD-183.9%

RNAC-10422.5%

FCF Margin (TTM)

IVVD-187.9%

RNAC-5322.4%

Net Income (TTM)

IVVD$-107M

RNAC$-154M

FCF (TTM)

IVVD$-110M

RNAC$-79M

EPS (TTM)

IVVD-$0.33

RNAC-$5.16

ROE (TTM)

IVVD-5973.0%

RNAC-321582.0%

ROA (TTM)

IVVD-4897.0%

RNAC-4761.0%

ROIC (TTM)

IVVD-5973.0%

RNAC-321582.0%

Cash

IVVD$160M

RNAC$148M

Debt

IVVD$0

RNAC$53M

Net Cash/Debt

IVVD$160M

RNAC$95M

Current Ratio (TTM)

IVVD5.87x

RNAC7.48x

Quick Ratio (TTM)

IVVD5.60x

RNAC7.19x

Debt/Equity (TTM)

IVVD0.00x

RNAC0.28x

Debt/Assets (TTM)

IVVD0.0%

RNAC0.0%

Interest Coverage (TTM)

IVVDN/A

RNACN/A

Net Debt/EBITDA (TTM)

IVVD0.00x

RNAC0.00x

Beta

IVVD1.32

RNAC0.74

52W Performance

IVVD-56.0%

RNAC-31.0%

YTD Performance

IVVD-71.2%

RNAC4.4%

% from 52W High

IVVD-76.5%

RNAC-35.9%

% from 52W Low

IVVD36.7%

RNAC26.0%

Asset Turnover (TTM)

IVVD0.27x

RNAC0.01x

FCF Yield (TTM)

IVVD-51.6%

RNAC-37.9%

Earnings Yield (TTM)

IVVD-50.5%

RNAC-74.3%

Dividend Yield (TTM)

IVVDN/A

RNACN/A

Rule of 40

IVVD-161.6

RNAC-5,343.1

EV/GP/RG

IVVD0.06

RNACN/A

Ticker research

View IVVD research View RNAC research

Metric	IVVD Invivyd Inc	RNAC Cartesian Therapeutics Inc
Market & Valuation
Market Cap	$212M	$207M
Enterprise Value	$52M	$113M
Price	$0.72	$7.06
P/E Ratio	N/A	N/A
P/S Ratio	3.64x	140.34x
EV/Sales	0.90x	76.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.34x	296.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.48x	-1.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.13x	473.62x
Revenue & Growth
Revenue (TTM)	$58M	$1M
Revenue Growth (YoY)	26.3%	-20.7%
Forward Rev Growth	44.8%	-14.0%
Profitability
Gross Margin (TTM)	92.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-191.7%	-6503.1%
Net Margin (TTM)	-183.9%	-10422.5%
FCF Margin (TTM)	-187.9%	-5322.4%
Net Income (TTM)	$-107M	$-154M
FCF (TTM)	$-110M	$-79M
EPS (TTM)	-$0.33	-$5.16
ROE (TTM)	-5973.0%	-321582.0%
ROA (TTM)	-4897.0%	-4761.0%
ROIC (TTM)	-5973.0%	-321582.0%
Financial Health
Cash	$160M	$148M
Debt	$0	$53M
Net Cash/Debt	$160M	$95M
Current Ratio (TTM)	5.87x	7.48x
Quick Ratio (TTM)	5.60x	7.19x
Debt/Equity (TTM)	0.00x	0.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.74
52W Performance	-56.0%	-31.0%
YTD Performance	-71.2%	4.4%
% from 52W High	-76.5%	-35.9%
% from 52W Low	36.7%	26.0%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.01x
FCF Yield (TTM)	-51.6%	-37.9%
Earnings Yield (TTM)	-50.5%	-74.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-161.6	-5,343.1
EV/GP/RG	0.06	N/A
Ticker research	View IVVD research	View RNAC research

Valuation

P/S Ratio

IVVD

3.64x

RNAC

140.34x

EV/FCF

RNAC

-1.43x

IVVD

-0.48x

Growth & revenue

Revenue Growth TTM

IVVD

26.3%

RNAC

-20.7%

Forward Revenue Growth

IVVD

44.8%

RNAC

-14.0%

Profitability & performance

Gross Margin

IVVD

92.2%

RNAC

0.0%

ROE

IVVD

-5973.0%

RNAC

-321582.0%

FCF Yield %

RNAC

-37.9%

IVVD

-51.6%

52-Week Performance

RNAC

-31.0%

IVVD

-56.0%

Detailed metrics comparison

IVVD

Invivyd Inc

RNAC

Cartesian Therapeutics Inc

Market Cap

IVVD$212M

RNAC$207M

Enterprise Value

IVVD$52M

RNAC$113M

Price

IVVD$0.72

RNAC$7.06

P/E Ratio

IVVDN/A

RNACN/A

P/S Ratio

IVVD3.64x

RNAC140.34x

EV/Sales

IVVD0.90x

RNAC76.18x

EV/EBITDA

IVVD0.00x

RNAC0.00x

P/B Ratio

IVVD1.34x

RNAC296.12x

P/FCF Ratio

IVVDN/A

RNACN/A

EV/FCF

IVVD-0.48x

RNAC-1.43x

PEG Ratio

IVVDN/A

RNACN/A

Forward P/E (NTM)

IVVDN/A

RNACN/A

Forward P/S (NTM)

IVVD3.13x

RNAC473.62x

Revenue (TTM)

IVVD$58M

RNAC$1M

Revenue Growth (YoY)

IVVD26.3%

RNAC-20.7%

Forward Rev Growth

IVVD44.8%

RNAC-14.0%

Gross Margin (TTM)

IVVD92.2%

RNAC0.0%

Operating Margin (TTM)

IVVD0.0%

RNAC0.0%

EBITDA Margin (TTM)

IVVD-191.7%

RNAC-6503.1%

Net Margin (TTM)

IVVD-183.9%

RNAC-10422.5%

FCF Margin (TTM)

IVVD-187.9%

RNAC-5322.4%

Net Income (TTM)

IVVD$-107M

RNAC$-154M

FCF (TTM)

IVVD$-110M

RNAC$-79M

EPS (TTM)

IVVD-$0.33

RNAC-$5.16

ROE (TTM)

IVVD-5973.0%

RNAC-321582.0%

ROA (TTM)

IVVD-4897.0%

RNAC-4761.0%

ROIC (TTM)

IVVD-5973.0%

RNAC-321582.0%

Cash

IVVD$160M

RNAC$148M

Debt

IVVD$0

RNAC$53M

Net Cash/Debt

IVVD$160M

RNAC$95M

Current Ratio (TTM)

IVVD5.87x

RNAC7.48x

Quick Ratio (TTM)

IVVD5.60x

RNAC7.19x

Debt/Equity (TTM)

IVVD0.00x

RNAC0.28x

Debt/Assets (TTM)

IVVD0.0%

RNAC0.0%

Interest Coverage (TTM)

IVVDN/A

RNACN/A

Net Debt/EBITDA (TTM)

IVVD0.00x

RNAC0.00x

Beta

IVVD1.32

RNAC0.74

52W Performance

IVVD-56.0%

RNAC-31.0%

YTD Performance

IVVD-71.2%

RNAC4.4%

% from 52W High

IVVD-76.5%

RNAC-35.9%

% from 52W Low

IVVD36.7%

RNAC26.0%

Asset Turnover (TTM)

IVVD0.27x

RNAC0.01x

FCF Yield (TTM)

IVVD-51.6%

RNAC-37.9%

Earnings Yield (TTM)

IVVD-50.5%

RNAC-74.3%

Dividend Yield (TTM)

IVVDN/A

RNACN/A

Rule of 40

IVVD-161.6

RNAC-5,343.1

EV/GP/RG

IVVD0.06

RNACN/A

Ticker research

View IVVD research View RNAC research

Metric	IVVD Invivyd Inc	RNAC Cartesian Therapeutics Inc
Market & Valuation
Market Cap	$212M	$207M
Enterprise Value	$52M	$113M
Price	$0.72	$7.06
P/E Ratio	N/A	N/A
P/S Ratio	3.64x	140.34x
EV/Sales	0.90x	76.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.34x	296.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.48x	-1.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.13x	473.62x
Revenue & Growth
Revenue (TTM)	$58M	$1M
Revenue Growth (YoY)	26.3%	-20.7%
Forward Rev Growth	44.8%	-14.0%
Profitability
Gross Margin (TTM)	92.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-191.7%	-6503.1%
Net Margin (TTM)	-183.9%	-10422.5%
FCF Margin (TTM)	-187.9%	-5322.4%
Net Income (TTM)	$-107M	$-154M
FCF (TTM)	$-110M	$-79M
EPS (TTM)	-$0.33	-$5.16
ROE (TTM)	-5973.0%	-321582.0%
ROA (TTM)	-4897.0%	-4761.0%
ROIC (TTM)	-5973.0%	-321582.0%
Financial Health
Cash	$160M	$148M
Debt	$0	$53M
Net Cash/Debt	$160M	$95M
Current Ratio (TTM)	5.87x	7.48x
Quick Ratio (TTM)	5.60x	7.19x
Debt/Equity (TTM)	0.00x	0.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.74
52W Performance	-56.0%	-31.0%
YTD Performance	-71.2%	4.4%
% from 52W High	-76.5%	-35.9%
% from 52W Low	36.7%	26.0%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.01x
FCF Yield (TTM)	-51.6%	-37.9%
Earnings Yield (TTM)	-50.5%	-74.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-161.6	-5,343.1
EV/GP/RG	0.06	N/A
Ticker research	View IVVD research	View RNAC research